Literature DB >> 6839179

Radial component of central myelin in shiverer mouse.

H Nagara, K Suzuki, J Tateishi.   

Abstract

'Radial component' of the central myelin was investigated in a neurological mutant mouse, shiverer, which is characterized by the lack of myelin basic protein and paucity of the major dense line in the CNS myelin. As has been noted previously in the normal as well as other neurological mutant mice, radial component consisted of rows of interlamellar tight junctions and was accompanied with electron lucent linear structures (ELLS) over the major dense lines. In the areas where major dense line had formed in shiverer CNS myelin, numerous ELLS run across the major dense lines and were not always associated with a fusion of double intraperiod lines. The possible role of ELLS in myelin formation is briefly discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6839179     DOI: 10.1016/0006-8993(83)90325-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  The shiverer mutation affects the persistence of Theiler's virus in the central nervous system.

Authors:  F Bihl; C Pena-Rossi; J L Guénet; M Brahic; J F Bureau
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Cultures of shiverer mutant cerebellum injected with normal oligodendrocytes make both normal and shiverer myelin.

Authors:  S Billings-Gagliardi; A L Hall; G B Stanhope; R J Altschuler; R L Sidman; M K Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

3.  Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice.

Authors:  T Uschkureit; O Sporkel; J Stracke; H Bussow; W Stoffel
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

4.  The role of myelin in Theiler's virus persistence in the central nervous system.

Authors:  Jean-Pierre Roussarie; Claude Ruffié; Michel Brahic
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.